Cagrilintide and retatrutide combination therapy enhances weight loss and metabolic outcomes in obese male rats

Related

• Retatrutide reduces weight and pain in adults with obesity

  The New England Journal of Medicine · 4 Oct 2026

• Retatrutide reduces bodyweight in obesity and type 2 diabetes

  Lancet · 4 Oct 2026

• Antibody reduced fat while preserving lean mass in mice

  JCI Insight · 6 Oct 2026

  

• Survodutide reduces weight in adults with diabetes and obesity

  The New England Journal of Medicine · 4 Oct 2026